Nektar Presents Positive Data for Novel Opioid Analgesic NKTR181 at the 2011 American Academy of Pain Management Annual Meeting

SAN FRANCISCO Sept. 21 2011 PRNewswire Nektar Therapeutics NASDAQNKTR today announced that positive proofofconcept data is being presented from its first Phase 1 clinical trial of NKTR181 at the American Academy of Pain Management AAPM 22nd Annual Clinica...